These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36539455)

  • 1. Simultaneous spectrofluorimetic determination of remdesivir and simeprevir in human plasma.
    El Sharkasy ME; Tolba MM; Belal F; Walash MI; Aboshabana R
    Sci Rep; 2022 Dec; 12(1):21980. PubMed ID: 36539455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma.
    Ramzy S; Abdelazim AH; Osman AO; Hasan MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 281():121625. PubMed ID: 35863184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An environmentally sustainable synchronous spectrofluorimetric method coupled with second derivative signal processing for simultaneous determination of velpatasvir and simeprevir in pharmaceutical and plasma samples.
    Ramzy S; Alshehri S; Abduljabbar MH; Althobaiti YS; Alzhrani RM; Almalki AH
    Spectrochim Acta A Mol Biomol Spectrosc; 2025 Feb; 326():125202. PubMed ID: 39332169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micelle sensitized synchronous spectrofluorimetric approaches for the simultaneous determination of simeprevir and ledipasvir: Application to pharmaceutical formulations and human plasma.
    Hamad AE; Mohammed BS; Derayea SM; El-Malla SF
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Oct; 239():118471. PubMed ID: 32474370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma.
    Elmansi H; Ibrahim AE; Mikhail IE; Belal F
    Anal Methods; 2021 Jun; 13(23):2596-2602. PubMed ID: 34019051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green fitted second derivative synchronous spectrofluorometric method for simultaneous determination of remdesivir and apixaban at Nano gram scale in the spiked human plasma.
    Batubara AS; Abdelazim AH; Gamal M; Almrasy AA; Ramzy S
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Apr; 290():122265. PubMed ID: 36608515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironment improvement protocol for the sensitive spectrofluorimetric determination of an hepatitis C virus antiviral (Simeprevir): application to human plasma.
    Derayea SM; A El Hamd M; Ali S; Samir E
    Luminescence; 2020 May; 35(3):393-399. PubMed ID: 31849179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ultrasensitive green synchronous factorized spectrofluorimetric approach for the simultaneous determination of Favipiravir and Molnupiravir: Application to pharmaceutical, environmental, and biological matrices.
    ElSherbiny MS; Eid SM; Kelani KM; Abdel Ghany MF; El-Olemy A; Hasan MA; Abbas MM
    Luminescence; 2024 Aug; 39(8):e4837. PubMed ID: 39113185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids.
    El Sharkasy ME; Tolba MM; Belal F; Walash M; Aboshabana R
    Luminescence; 2022 Jun; 37(6):953-964. PubMed ID: 35343627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First derivative synchronous spectrofluorimetric method for the simultaneous determination of propofol and cisatracurium besylate in biological fluids.
    El Sharkasy ME; Walash M; Belal F; Salim MM
    Luminescence; 2020 Mar; 35(2):312-320. PubMed ID: 31746124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simeprevir oxidative degradation product: Molecular modeling, in silico toxicity and resolution by synchronous spectrofluorimetry.
    Attia KAM; El-Abasawi NM; El-Olemy A; Serag A
    Luminescence; 2018 Mar; 33(2):382-390. PubMed ID: 29124899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and first derivative synchronous spectrofluorimetric methods for the simultaneous determination of cisatracurium and nalbuphine in biological fluids.
    El Sharkasy ME; Walash M; Belal F; Salim MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 228():117841. PubMed ID: 31784219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrofluorimetric determination of the anti-Covid 19 agent, remdesivir, in vials and spiked human plasma.
    Attia TZ; Boushra JM; Abdel Hakiem AF; Lashien AS; Noureldeen DAM
    Luminescence; 2022 Jul; 37(7):1192-1199. PubMed ID: 35548893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2
    Gammeltoft KA; Zhou Y; Duarte Hernandez CR; Galli A; Offersgaard A; Costa R; Pham LV; Fahnøe U; Feng S; Scheel TKH; Ramirez S; Bukh J; Gottwein JM
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0268020. PubMed ID: 34097489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
    Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
    Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eco-friendly and cost-effective HPTLC method for quantification of COVID-19 antiviral drug and co-administered medications in spiked human plasma.
    Ghozzy EA; El-Enany NM; Tolba MM; El Abass SA
    Sci Rep; 2024 May; 14(1):10025. PubMed ID: 38693137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eco-Friendly Synchronous Spectrofluorimetric Method for Simultaneous Determination of Remdesivir and Acetyl Salicylic Acid in Spiked Human Plasma.
    Aboelghar SM; Hegazy MA; Wagdy HA
    J Fluoresc; 2024 Aug; ():. PubMed ID: 39150458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells.
    Nguyenla X; Wehri E; Van Dis E; Biering SB; Yamashiro LH; Zhu C; Stroumza J; Dugast-Darzacq C; Graham TGW; Wang X; Jockusch S; Tao C; Chien M; Xie W; Patel DJ; Meyer C; Garzia A; Tuschl T; Russo JJ; Ju J; Näär AM; Stanley S; Schaletzky J
    Sci Rep; 2022 Nov; 12(1):18506. PubMed ID: 36323770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and synchronous spectrofluorometric determination of the recently administered drugs for treatment of COVID-19 favipiravir and apixaban.
    Elama HS; Zeid AM; Shalan SM; El-Shabrawy Y; Eid MI
    Sci Rep; 2022 Dec; 12(1):21520. PubMed ID: 36513795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.